THC

CornMonkey-Original

it’s often best to just feed the insomnia THC. . .

MidnighT0k3r

I'm not suggesting you take it so much as you read about it. There are studies being done and I for example am very eager for when cannabis based medicine is more of a thing.  Not just for stuff that I discussed above but sooo much more.  For example, there's another type of cannabis that also not rich in thc and it's chemotype 4 which is rich in cbga. It helps me with reducing my migraine frequency, lowers my inflammation and chronic pain, reduces my ibs-c symptoms, reduces my neuropathy from stenosis and spinal injury. I can't get medicine for some of these things outside of cannabis.  So... what I'm getting at is I'm just trying to share inflammation that cannabis isn't just all about getting high off thc. The plant actually offers significantly more medicinal benefits with the other cannabinoids and chemotypes. It is however mostly fair to assume when you smell cannabis it is 95% of the time chemotype 1 cannabis which is rich in THC and intoxicating because of it.  If however you really did want to look deeper into it and consider trying cbd (id recommend talking to a doctor or pharmacist first to make sure cbd doesn't interact with anything you may already be taking).... You should know there are different types of cbd products. Ones made with isolate have no detectable levels of thc. This doesn't mean no thc, it means of it is there it's below the levels we can measure. So like below 0.001% or something like that.  Ones made from anything else like full or broad spectrum extracts will contain small levels of thc that you may want to avoid.  Also with edibles not everyone processes it the same so what 5mg feels like for one person can be different to another.

ValuableHippo3931

whats the ticker for THC drinks

skyplt29

I agree Geo. I get these 8-K reports directly from Tilray Investor Relations so knew this was a debt for equity swap. This is not as bad as other dilutions but I would like to see them able to start paying down debt from operating profits, not issuing more shares. I am not sophisticated enough to see the relationship between shorting a stock, then swapping equity to cover when the stock price gets driven down. But one has to wonder how the stock could get driven down from 4.50USD to 4USD (10%) on no news. Perhaps this has something to do with that plummet. I sincerely hope Tilray's C-suite is executing a well thought out strategic plan to increase efficiencies in the brands they have acquired, pay off debt, and move forward with synergies (perhaps even using their alcohol distribution network to move CBD and THC based drinks). But I am growing tired of the constant dilution, especially when Simon/Merton state on Q calls that this phase of the company's growth is over. So yes, this was not a terrible filing, but shareholders are paying for this when it is time for operating profits to pay off debt.

Apple2o

A lot of you have never had a blunt laced with THC diamonds and it shows

CornMonkey-Original

well on my way to 120mg of THC today - we are not the same. . .

grimeyGR1

They don't have winning brands. They sell blended 2x1g joints of floor sweepings and lab inflated THC boof

Creepy_Translator_69

Trying to stay up for the ADBE earnings call THC got other ideas

Strong-Comment-7279

These "investments" in general - vaping, tobacco replacement, THC vehicles.

Glittering_Dig3798

When I quit vaping THC I developed chronic diarrhea. Didn't connect the dots for a month or two. One night I realized the correlation, reupped, and have been better since. Just my $0.02

Orennji

What I'm trying to wrap my head around is the fact that their volume of smokable ounces has actually been mostly stable from 2023 to 2026 while their THC milligram's declined. One interpretation I can think of is that their product mix is trending towards low potency medical consumption favored by a mostly older/elderly demographic. Just a guess, though, since I haven't looked at any detailed breakdown based on form factor or strains.

Orennji

Been using LLMs as unpaid interns to sift through OMMU trends, with some quick manual skimming to double check. Pretty interesting trends here for THC mg's per storefront, once you zoom way out and look at the entire market: > THC volume per store: 2023 → 2026 Operator 2023/store 2026/store Change Trulieve 1.01M 647k −36% MÜV / Verano 415k 602k +45% Curaleaf 667k 633k −5% AYR  781k 603k −23% Surterra 658k 275k −58% FLUENT 393k 629k +60% Sunnyside / Cresco 197k 399k +103% GTI / RISE 233k 921k +296% Cookies 267k 465k +74% Jungle Boys 252k 644k +156% Sunburn 553k 889k +61% GrowHealthy 315k 520k +65% Sanctuary 231k 346k +50% Insa 162k 480k +197% The Flowery 926k 521k −44% The big story isn't simply that the independents are growing. A number of the smaller/premium operators have dramatically improved their stores' throughput. The standout is GTI: 233k → 921k THC mg/store/week That's almost a 4× increase while going from 9 to 24 stores. Jungle Boys is also striking: 252k → 644k, +156% And Sunburn: 553k → 889k, +61% Meanwhile, Trulieve went from an extraordinary 1.01M/store to 647k, despite growing from 127 to 170 stores.  One thing I find particularly interesting The ranking has changed substantially: 2023: Trulieve — 1.01M Flowery — 926k AYR — 781k Curaleaf — 667k Surterra — 658k Sunburn — 553k MÜV — 415k FLUENT — 393k GrowHealthy — 315k Cookies — 267k Jungle Boys — 252k 2026: GTI — 921k Sunburn — 889k Jungle Boys — 644k Curaleaf — 633k FLUENT — 629k AYR — 603k MÜV — 602k Trulieve — 647k (actually #3 if sorted strictly; the close grouping makes the ranking easy to misread) GrowHealthy — 520k Flowery — 521k Insa — 480k Cookies — 465k The important takeaway is that the best independents aren't merely surviving against the MSOs—they've become much more productive per location. And this makes Sunburn particularly interesting: at 889k mg/store, it's now producing about 37% more THC volume per store than Trulieve, despite Trulieve's enormous scale.

trent_upscale

Laying in bed rn, mind numbed by THC. What do you want from me

fuentescoffee

Worth flagging for anyone reading this as one more store on the pile: Georgia stopped being the market most people still have in their heads about ten weeks ago. SB 220 took effect July 1. The 5% THC cap is gone, replaced by a 12,000mg cumulative possession ceiling, and flower and vaporizers are on the menu for patients 21+ — smoking botanical cannabis is still not permitted, so inhalation is vape-only. Qualifying conditions widened at the same time: lupus, HIV and IBD added, and the "end-stage" limiter stripped from cancer, MS and Parkinson's. That last one is the change most likely to actually move the registry. So a Georgia store opened this month isn't comparable to one opened last year — different basket, different eligible pool. The number I'd want here is same-store growth at the existing Georgia locations since July 1, not the footprint count. One thing that cuts against footprint framing generally: post-rescheduling, licensed independent pharmacies with DEA registration can dispense in Georgia, and Trulieve said on July 1 it was already supplying a dozen-plus. If that channel scales, owned stores stop being a clean proxy for Georgia share.

mfairview

as is always, cost will be passed onto the consumer and only the most efficient or notable companies will prevail. the one notable thing I would say about THC products is that it can exist in many form factors, from inhalents to drinks to foods. that gives it a massive surface to operate in.

AverageNo130

A handful of congressional Republicans threatened this week to upend their leadership’s agenda in protest of legislation to [delay the scheduled federal recriminalization of hemp THC products](https://www.marijuanamoment.net/house-passes-bill-to-delay-hemp-thc-product-ban-sending-it-to-trumps-desk/) from taking effect. Two Democrats—Reps. Marie Gluesenkamp Perez (D-WA) and Jared Golden (D-ME)—voted with Republicans to approve the rule, 210-208. MM

AverageNo130

>U.S. House Passes Spending Bill Delaying Federal Hemp THC Ban, Sending It to President Trump. MH

skyplt29

Rep. [Chip Roy](https://www.cnbc.com/video/2025/08/28/rep-chip-roy-on-congressional-stock-trading-ban-u-s-governments-stake-in-intel.html), R-Texas, sent a letter on Monday to House Appropriations Committee Chair [Tom Cole](https://www.cnbc.com/tom-cole/), R-Okla., and House Budget Committee Chair [Jodey Arrington](https://www.cnbc.com/video/2026/07/30/this-is-emergency-funding-says-house-budget-chair-on-reconciliation-3-point-0.html), R-Texas, outlining his concerns with the stopgap spending measure, among them its funding for Planned Parenthood and the absence of a ban on hemp products that contain THC, the psychoactive chemical in marijuana. “I have serious concerns about simply extending the status quo. Members should be clear about what passage of this legislation would mean: Congress would once again affirmatively fund policies we have spent months fighting to change,” Roy wrote. And Rep. Andy Harris, R-Md., who chairs the Freedom Caucus, [told Punchbowl News](https://x.com/JakeSherman/status/2094533287830245683?s=20) he would vote to block the rest of the GOP’s agenda for the week over his objection to the spending measure. But their opposition was not enough to complicate the vote. With Democratic support, Johnson was able to pass the funding measure even with some GOP defections.

AverageNo130

Endovia Health Sciences says it plans to make its next Food and Drug Administration (FDA) submission for CannEpil in the coming week and request a meeting with the agency to discuss the cannabinoid drug’s regulatory and development pathway. CannEpil is a pharmaceutical-grade oral formulation made with isolated cannabidiol (CBD) and tetrahydrocannabinol (THC). The drug was originally developed for drug-resistant epilepsy, and Endovia holds exclusive worldwide rights to develop and commercialize it for human and veterinary uses. MH **Endovia Health Sciences:** In August 2026, Splash Beverage Group completed a corporate transformation and rebranded into [Endovia Health Sciences](https://www.sec.gov/Archives/edgar/data/1553788/000173112226001047/e7845_ex99-1.htm) (trading on the NYSE American under the ticker symbol **EDVA**

AverageNo130

The U.S. House of Representatives is expected to consider a bill this week that contains provisions to [delay the federal recriminalization of hemp THC products](https://www.marijuanamoment.net/senate-rejects-amendment-to-keep-hemp-thc-product-ban-on-track-for-november-teeing-up-delay-trump-pushed-for/) that is currently scheduled to take effect in November. The legislation has already been approved by the Senate. MM

AverageNo130

A low-THC, full-spectrum cannabis extract significantly improved core and associated symptoms of autism spectrum disorder in children and adolescents compared with placebo, according to a Phase II/III [randomized clinical trial](https://www.neurotherapeuticsjournal.org/article/S1878-7479%2826%2900203-5/fulltext). The study examined children with moderate-to-severe autism spectrum disorder (ASD). MH I guess this is bullish for CWBHF and their own autism drug in phase 2 trial.

Hwangoutpltr

If your reading this and you're high on THC, you left your car interior light on

answerguru

You can buy THC powder to just make your own. In bulk around 1000mg for $120-150.

danaknyc

Only issue with THC drinks is that they’re $5/can. Also, the state by state limits are idiotic. NY is great with the 10mg cans, but go to New Orleans or Mass and you’re capped at 5mg. Looking forward to the day where I can pick up a six pack for $15 and be on with life.

GeoLogic23

Hill Street (now Hill Incorporated) went [bankrupt last year](https://www.thenewswire.com/press-releases/1ArbF4mvN-hill-incorporated-makes-assignment-in-bankruptcy-under-the-bankruptcy-and-insolvency-act-canada.html), so idk if Lexaria has regained those rights or not. >**November 21, 2025.**... Hill Incorporated....announces today that it has made an assignment in bankruptcy pursuant to the *Bankruptcy and Insolvency Act*. >Due to dramatic price compression, difficulty in collections of accounts receivable, and other significant challenges in the cannabis industry affecting the Company’s DehydraTECH licensing business, along with the significant cash outlays and costs... I just know Lexaria specfiically said they had "renewed corporate interest" from both CBD and nicotine sectors. So yea, my initial though was something regarding Cannadips. I initially found Lexaria's comment about renewed interest from the CBD sector after Tilray released their pouch product. That made me go look at Lexaria again, as they are the main connection I know to CBD/THC pouch products. And pouches are like the key product for big tobacco maintaining their sales right now. Cannadips also had an ex-Altria guy running them for a while, and Cannadips are an investment by Poseidon Asset Management. Besides being longtime cannabis investors, Poseidon has also invested in hemp beverages (RYM), and they were early investors in JUUL. So they already have experience selling companies to Altria.

Kbarbs4421

After digging into this one a bit.... Lexaria developed bioabsorption technology that significantly improves absorption of cannabinoids, nicotine, and likely other molecules. Altria took a stake in the company (16.67%..?) and also acquired the rights to use the tech for oral nicotine products, in exchange for royalty payments. There is no cannabinoid based relationship between the companies...though there obviously could be if fed law/reg changes. Altria has the option to outright acquire the company, which would bring their patents under Altria ownership. It would also eliminate the oral nicotine royalty payments. Rights to use the tech for cannabis products has been a) outright sold to Hill Street BevCo for consumer recreational products (which has been sublicensed to others, including Lume, Cannadips, etc?), and b) long term licensed (through 2030? 2035?) for sub-0.3% THC formats to Cannadips. Meaning Lexaria no longer owns the rec rights and does not control the cannabinoid/wellness rights. The only thing they're left with is the theoretical FDA approved pharma line, right? Initially, this intrigued me from a cannabis perspective. If anything, it seems more like a nicotine play with a pharma kicker for Altria. Perhaps I'm misreading it. Does make me wonder if there's a relationship in the works between Altria/Cronos and Hill Street. Or Lume. Or Cannadips.

SwordfishOk504

Possession of any amount of recreational cannabis is an imprisonable offence in Texas. And yet in many places where Texans buy beer, they can also find drinks infused with tetrahydrocannabinol (THC), the psychoactive component of cannabis. THC drinks are flying off the shelves—and not just in the Lone Star State. Their rise stems from changing social mores and regulatory confusion. Start with the first. Alcohol sales are declining as youngsters drink less than older generations. But some teetotallers welcome a buzz. THC was once stigmatised for leaving users sprawled and giggling on the sofa, wrist-deep in a bag of crisps. Today, though, it has a veneer of “wellness”. Many THC drinks have few or no calories; some include ostensibly healthy extras such as plant extracts. Makers boast that they do not cause hangovers. Some restaurants have even started to offer them, noticing a rise in “cocktail culture”. thc drinks come in a variety of strengths, so pay careful attention to the dosage: consuming 25mg rather than 2.5mg can lead to several deeply unpleasant hours. According to the Hemp Beverage Alliance, a trade group, in 2025 the number of distribution points more than doubled (from 133,500 to 306,000), as did the sales by volume (from about 700,000 case equivalents to 1.6m), from a year earlier. The Brightfield Group, a cannabis consultancy, predicts that revenue from THC drinks could exceed $4.4bn by the end of the decade, up from less than $200m in 2020. Total Wine, America’s biggest wine retailer, sells them in 22 states (there are 24 where cannabis is illegal). Their rise is owed partly to the morass of legislation governing American agriculture, known as the farm bill. Its most recent version lets farmers grow hemp with a THC content of no more than 0.3% by dry weight; anything stronger is classified as marijuana and remains illegal under federal law. But manufacturers can extract THC from large quantities of legal hemp and use it to make drinks containing intoxicating doses. Anti-cannabis lawmakers have noticed: last year Congress passed legislation that would limit THC to 0.4mg per container, in effect killing the hemp-drinks sector. But the Senate recently voted to briefly postpone the crackdown, and on August 10th a bipartisan bill was introduced that would exempt THC drinks from the restrictions and regulate them like alcohol. Its sponsors do not want to kill a golden, if slightly stoned, goose. This would open the federal government to charges of hypocrisy for approving one form of hemp while outlawing another. But it would also boost businesses and protect a steady stream of tax revenue. The industry is already high. Whether it becomes mighty—or goes up in smoke—will depend on lawmakers. ■

ValuableHippo3931

THC drinks are the next thing so whats the ticker

mfairview

AI Research 1. Final Adult-Use Rescheduling OrderExpected Outcome: Following the public release of the 2,533-page DEA transcript on August 25, 2026, Chief ALJ Derek Julius is highly expected to formally recommend shifting adult-use cannabis to Schedule III. DEA Administrator Terry Cole will then issue the final agency rule. This will effectively eliminate the 280E tax penalty for recreational multi-state operators (MSOs), mimicking the tax relief given to state-licensed medical operators.When to Expect It: Q4 2026 (October – November). Following the closing briefs from designated hearing participants, the administrative transition is expected to conclude before the winter recess. 2. SAFE Banking Act of 2026 (H.R. 9471) Committee VotesExpected Outcome: The bill faces a deeply divided Congress. However, because President Trump explicitly issued an Executive Order backing federal cannabis reclassification, the bill has a high probability of passing out of the House Financial Services and Judiciary Committees. It is expected to clear the House floor but face heavy structural gridlock in the Senate.When to Expect It: November – December 2026. Expect legislative momentum to peak during the post-election "lame duck" congressional session. 3. Decisions on MSO RICO Class-Action DismissalsExpected Outcome: Federal judges in Illinois and Connecticut are reviewing motions to dismiss Murray v. Cresco Labs and Duke v. Curaleaf. The court is expected to deny the MSOs' motions to dismiss. This will force the cases into discovery over whether MSOs illegally marketed recreational items as having clinical, unapproved medical benefits. Concurrently, Palomar Insurance' parallel lawsuits to completely deny policy coverage for these operators will likely proceed, creating a severe capital strain on corporate legal defense budgets.When to Expect It: Q1 2027 (January – March). Federal docket timelines for complex multi-party RICO actions typically rule on initial motions to dismiss within 6 to 9 months of their initial mid-2026 filing dates. 4. 2018 Farm Bill Hemp Loophole ClosureExpected Outcome: The enforcement date to officially close the structural loophole on unregulated hemp-derived cannabinoids will take effect. This is expected to instantly wipe out nearly 95% of existing synthetically derived or high-THC hemp products from gas stations and bodegas nationwide, consolidating the consumer market directly back into heavily regulated, state-licensed dispensaries.When to Expect It: November 12, 2026 (Locked-in regulatory effective date).

babaganoush-ish

From chatgpt: **My hypothetical Julius ruling** If I actually had to write the bottom line after this record, mine would probably look approximately like this: **FINDINGS** The record establishes that marijuana presents meaningful risks of abuse and adverse health consequences. The evidence further demonstrates substantial variation among marijuana products with respect to potency, formulation, route of administration and dosage. The opponents have presented credible evidence concerning cannabis-use disorder, psychiatric effects, impaired driving, high-potency products and limitations in portions of the medical literature. However, the evidence does not establish that marijuana lacks a currently accepted medical use. HHS’s scientific and medical evaluation concluded otherwise, and the Government presented evidence supporting that determination. The opposing parties identified limitations in that analysis but did not sufficiently undermine its central conclusion. Moreover, evidence concerning the risks associated with marijuana does not, without more, establish that Schedule I remains the appropriate classification. **CONCLUSION** After consideration of the administrative record and the applicable statutory factors, I would recommend that the marijuana presently subject to this proceeding be **transferred from Schedule I to Schedule III of the Controlled Substances Act**, subject to the regulatory controls applicable under federal law. **But I would attach significant caveats** This is where I think Julius could surprise cannabis investors. A **Schedule III recommendation doesn’t require him to endorse the cannabis industry**. He could write a fairly harsh 100+ page decision cataloguing high-potency THC, psychiatric risks, impaired driving, dependence, questionable medical claims and deficiencies in state regulatory systems… …and still conclude: **Schedule III.** Those two things aren’t contradictory. In fact, after reviewing the testimony, I think that’s one of the more plausible outcomes: **a reluctant, tightly reasoned Schedule III recommendation with extensive findings about marijuana’s risks.** **What could change my 70–80% assessment?** The **post-hearing briefs**. That’s important because Julius’s preliminary order specifically said there would be no oral closing arguments; instead, parties would submit post-hearing briefs under 21 CFR §1316.64. And right now DEA’s public 2026 NPRM page lists all 11 transcripts plus the transcript/post-hearing briefing order, but **does not presently list the parties’ post-hearing briefs themselves**. Those briefs matter because a witness can give persuasive scientific testimony but still lose on the **law**. The briefs are where each side connects the testimony to the CSA and explains why Julius legally can—or cannot—reach Schedule III. So I wouldn’t move my probability substantially higher than \~80% until seeing those arguments. **One more important point** Even if my hypothetical Julius issues: **RECOMMENDATION: Schedule III** that **doesn’t itself reschedule marijuana**. Julius is the ALJ developing the administrative record and recommended findings. The ultimate agency rulemaking still has subsequent steps. DEA describes the process as formal rulemaking involving administrative review after the evidentiary proceeding.

babaganoush-ish

From chatgpt: **My hypothetical Julius ruling** If I actually had to write the bottom line after this record, mine would probably look approximately like this: **FINDINGS** The record establishes that marijuana presents meaningful risks of abuse and adverse health consequences. The evidence further demonstrates substantial variation among marijuana products with respect to potency, formulation, route of administration and dosage. The opponents have presented credible evidence concerning cannabis-use disorder, psychiatric effects, impaired driving, high-potency products and limitations in portions of the medical literature. However, the evidence does not establish that marijuana lacks a currently accepted medical use. HHS’s scientific and medical evaluation concluded otherwise, and the Government presented evidence supporting that determination. The opposing parties identified limitations in that analysis but did not sufficiently undermine its central conclusion. Moreover, evidence concerning the risks associated with marijuana does not, without more, establish that Schedule I remains the appropriate classification. **CONCLUSION** After consideration of the administrative record and the applicable statutory factors, I would recommend that the marijuana presently subject to this proceeding be **transferred from Schedule I to Schedule III of the Controlled Substances Act**, subject to the regulatory controls applicable under federal law. **But I would attach significant caveats** This is where I think Julius could surprise cannabis investors. A **Schedule III recommendation doesn’t require him to endorse the cannabis industry**. He could write a fairly harsh 100+ page decision cataloguing high-potency THC, psychiatric risks, impaired driving, dependence, questionable medical claims and deficiencies in state regulatory systems… …and still conclude: **Schedule III.** Those two things aren’t contradictory. In fact, after reviewing the testimony, I think that’s one of the more plausible outcomes: **a reluctant, tightly reasoned Schedule III recommendation with extensive findings about marijuana’s risks.** **What could change my 70–80% assessment?** The **post-hearing briefs**. That’s important because Julius’s preliminary order specifically said there would be no oral closing arguments; instead, parties would submit post-hearing briefs under 21 CFR §1316.64. And right now DEA’s public 2026 NPRM page lists all 11 transcripts plus the transcript/post-hearing briefing order, but **does not presently list the parties’ post-hearing briefs themselves**. Those briefs matter because a witness can give persuasive scientific testimony but still lose on the **law**. The briefs are where each side connects the testimony to the CSA and explains why Julius legally can—or cannot—reach Schedule III. So I wouldn’t move my probability substantially higher than \~80% until seeing those arguments. **One more important point** Even if my hypothetical Julius issues: **RECOMMENDATION: Schedule III** that **doesn’t itself reschedule marijuana**. Julius is the ALJ developing the administrative record and recommended findings. The ultimate agency rulemaking still has subsequent steps. DEA describes the process as formal rulemaking involving administrative review after the evidentiary proceeding.

No_Presentation9490

You could also have just bought Altria who is getting into THC and has massive market penetration already and be paid 6% in yearly dividends just to hold the position

aznexile602

This comment made me laugh. But I am also pretty high right now. Both on the THC and the ETH.

SwordfishOk504

No, loophole that has allowed THC products being sold under the guide of "Hemp" is rightfully being closed.

it_wasntt_me

It’s like a THC tickle more than a high

Altair82

Look into hippocampus and tips for improving its health (hint: lots of cardio, sleep, and nutrition) Look into Delta 8 to replace THC. It doesn't flood your brain with as much dopamine Look into shrooms microdosing for plasticity and also Lion's Mane for neural production Short answer: yes. You can claim back your memory. I did it and I'm sure you can also. I started smoking at 15 also.

skyplt29

Really very good advice, and timely. Though I know all of these things, greed has a way of clouding my judgement. Yep...weedstocks has crept up to 25% of my portfolio. That's not good. I got sucked in last December on the S3 Executive Order. I did not sell that news event! The upshot is the shares are held in tax free accounts, so if they explode it is a home run. The bad news is this means I cannot write off the losses either, which continue to fester this year. Risk/reward? That's where the major rethink is happening. I know weedstocks are high risk. Unfortunately, I am beginning to think the reward is just not there to justify that risk. This primarily has to do with the legal/regulatory hurdles and what we have clearly seen over the last ten years of how low a priority this is for the USA government and how much resistance there is from well funded organizations looking to keep children off drugs and sniffer dogs employed. I still believe medical applications and low dose THC drinks is where the potential lies. I am astounded the vast majority of the population either don't know or don't care (perhaps both) about viable alternatives to destructive drugs (Tylenol, opioids) and alcohol. Wow, just wow. I thought by now the evidence would have convinced politicians...but I think the pharmaceutical and alcohol lobby groups are simply too well established and the misinformation too deep. Wish it was otherwise...but definitely revisiting my risk/reward assessment. Will look to reduce this portion of my portfolio to around 10%.

TCNNF_Moon-_

Trulieve all lined up for next week. I think we may be looking at only S3 medical and not rec. I have a feeling they will stretch us all out a while longer until the real reform that’s needed actually happens Medical should be controlled and rec also, but with different allowed THC levels. Deschedule rec by 2030 maybe. 🤔 With this sector though. No one knows. Well expect for all the people that do know…

Wows_Nightly_News

HTZ the new THC

floatingdownthesound

Really appreciate this, easily the most useful comment I've gotten, and it hits harder coming from someone who maintains the same 50-state column. Shipped most of it: Added the second axis you called out. There's now a "sales live" flag (live / launching / blocked / none) separate from legal status, so Virginia reads legal + launching instead of pretending to be an operating market. And the last-action date per bill is now visible on mobile, since a stale "in committee" with no date is worse than nothing. The per-provision hemp countdown is the one I'm sitting on. You're right that one number flattens a staged calendar, so I'll break out total-THC, the 0.4mg cap, and the manufactured-cannabinoid exclusion into separate dates once the delay actually gets signed. The status field that quietly rots is the exact fight. If you ever want to compare notes on keeping Budpedia current, I'm in. Thanks again.

fuentescoffee

Solid build, and putting "legislative data via LegiScan, CC BY 4.0" on the page already puts you ahead of most trackers in this space. Two bits of honest feedback, from someone who maintains the same 50-state legal-status column on a cannabis directory (disclosure: I run Budpedia — not a bill tracker, but that status field is the part that quietly rots on me): The 24 / 18 / 1 / 7 bucket split will bite you on edge cases. DC is the classic — possession legal, retail sales blocked by the congressional appropriations rider — and it doesn't sit cleanly in any of the four. Same issue with states that legalized but haven't opened stores. A second axis ("legal" vs "sales live") fixes most of it. Second: the single "123 days to Dec 11" hemp countdown flattens what's actually a staged calendar. The CR moved several distinct pieces to that date — total-THC measurement, the 0.4mg/container cap, the manufactured-cannabinoid exclusion — and an operator reading one number plans for one cliff. Per-provision dates would be the highest-value thing you could add. Smaller: surface last-action date per bill. LegiScan's status lags in a few states and a stale "in committee" is worse than showing nothing.

Gambelero

Good point Sky. That “lack of interest” makes me skeptical that people in Congress will put in the hard work necessary to build a regulatory framework that allows non-intoxicating hemp for various uses but closes the high THC loopholes. They never meant to allow the high THC exceptions in the first place. My expectation has always been that they would kick the can down the road with another one year stay on the hemp ban. Fighting over a one month extension would seem to indicate that they seriously want fix things.

AverageNo130

A U.S. Senate dispute over whether to [implement a forthcoming ban on hemp THC products on time as scheduled or instead delay it](https://www.marijuanamoment.net/senate-rejects-amendment-to-keep-hemp-thc-product-ban-on-track-for-november-teeing-up-delay-trump-pushed-for/) in order to give lawmakers more time to craft regulations as an alternative to prohibition has transcended typical partisan and ideological lines. In a vote of 61-32 34 Democrats and one independent who caucuses with Democrats took the pro-hemp position by voting to table the prohibition amendment from  Sen. Ted Budd (R-NC) . MM

Kbarbs4421

> [Trump laid out the argument to Sen. Ted Budd (R-N.C.) for why the White House supports a provision in the stopgap funding bill that would delay the ban by about a month .... The White House is working on a broader framework addressing THC products for medicinal uses, and officials are concerned the ban could complicate those plans. .... White House liaison James Braid .... committed to no further delays — beyond the one included in the short-term funding measure.](https://www.axios.com/2026/08/05/trump-ted-budd-senate-republicans-hemp)

GeoLogic23

It at least pushes it into the lame duck session, where sometimes things actually get done. The last Farm Bill was passed during a lame duck session. Imo they have to do something to make hemp not conflict with Trump's CBD policy, which is up to 3mg THC.

GeoLogic23

>If there was a burning desire for them, people would go get them. First of all, you'd make the worst marketer. Half of building a brand is just getting it in front of your target consumer, not making them come to you. The drinks market does not target people who go to dispensaries. If you're routinely smoking cannabis, drinks are probably not your market. But there is a [clear market](https://www.reddit.com/r/weedstocks/s/G3mi60kURn) for them. And you really need to read more about beverage distribution, and how critical it is to keeping costs down, because drinks are heavy. You simply cannot build a national beverage brand without tons of distribution partners. [See how you still think THC drinks cost $6 each? ](https://www.binnys.com/extras/thc/) You're just choosing to imagine what the beverage market is like based on the past, instead of realizing how it has changed in recent years since retail shifted in the US. Take Celsius for an example of the importance of distribution for beverages. If people wanted to drink Celsius they would have went and got them, right? **But they didn't for years**, until they were in Pepsi's distribution line and suddenly were right in front of people's faces at grocery stores and were the hottest energy drink for a while. I've literally tried Celsius myself, for no other reason than it was there in front of me. I decided they sucked, but I tried them multiple times. >The drinks guys are burning a ton of cash and diluting like crazy in order to bet on a future that may or may not happen. I much prefer the people making money off selling products that are desirable today. Why are you trying to turn this conversation into a Canopy vs Auxly/Cronos debate or something? I told you I've been invested in both Cronos and Auxly for years. I'm trying to explain why they are simply a completely different investment thesis. And again, Canopy has NOT been burning money on drinks infrastructure. **They've been burning money a lot of other ways.** They already have the Constellation infrastructure if they need it. Now Tilray on the other hand has been burning money on drinks infrastructure, because they don't have a Constellation to rely on.

skyplt29

I suspect many of us here could share some eye watering (soul sucking?) stories. Believe it or not I got completely out just before the Nov 2024 election as I suspected Harris would lose. I realized significant losses but spent most of 2025 on the road to financial recovery. I was doing well in other sectors, but by late Nov/early Dec 2025 there was the promise of an Executive Order on S3. Trump was also shouting "Drill baby drill" and oil was around 57USD a barrel, and projected to go lower as production ramped up. Seemed like a no-brainer to sell some underperforming oil stocks and jump back into this sector for the long awaited rescheduling. Biggest mistake of my investment career! Watching these weedstocks move toward ATLs whilst those oil stocks I used to own hit all time highs is excruciating. Who knew the President who had promised not to get into any overseas "forever wars" would put us right into the middle of one with bothering to run it past Congress. Who knew Iran would wake up to their power over the Strait of Hormuz. Wow. Not sure where this is all headed. If Iran (and Oman) begin taxing ships transiting Hormuz I doubt oil will get much lower. Cost of living will continue to skyrocket...and that jobs report on Friday, sobering. But who the fuck knows anymore. On the 17th of Aug we will supposedly getting some news on rec S3, but again, who the fuck cares anymore. I experienced some incredible gains with Canopy when Constellation jumped in with 5B. Rode that from 32CAD to 70CAD. Wish I never experienced that high. I then got hung out to dry when I was over leveraged on margin when Hindenburg broke the story on Aphria. Seen it all...fake walls, carmalized lungs, THC absorbed by aluminum cans, threat of being arrested if it was found out you were invested in weedstocks, and the kicker, the S3 Executive Order being a "sell the news event" 45 minutes before the actual signing. Ironically, the Situational Awareness hedge fund implosion and Leopold Aschenbrenner's massive losses (due to being overextended on AI investments) brought back harsh memories of my margin buys on Aphria. I lost over 200K on that (had to sell other investments to cover). Ever since I have been trying to make that back...I haven't. On the bright side, I have never bought on margin again. It's one of the reasons I am reluctant to get into Puts and Calls. Whereas I used to write off the negative comments of the FoodCooker types, the sad part is they are being supported by the share price action. Too early? Too dumb? Too egotistical to admit I made a huge error? Likely a combination of all of that. But I remain here because of my personal experience with CBD and it making life so much better in terms of arthritis pain management. Why they still sell Tylenol is beyond me. I won't go near that liver stretching drug. Now a low calorie THC drink that provides a measure of 'taking the edge off' but one would need to drink several gallons to get stoned is a good thing I believe. Perhaps one day people will be order a THC drink and not feel as though they are a drug addict. Sad that alcohol is not considered in the same light. Hard to know what is behind a one month extension on the hemp laws...it does not seem worthwhile. The astounding thing about all of this is I actually still believe there is going to be a breakthrough here. As you say, it also means I was wrong. I was definitely wrong.

skyplt29

Another week in weedstocks has come and gone. A long winded summary: Mixed feelings... Though not a fan of the present government of my country, I am relieved to see Todd Blanche get the vote. As far as DOJ's go, Blanche is about the closest this sector has come to having someone in that position who is at least somewhat understanding of the situation. We'll see. I am hopeful of something on 17 August, but anyone who has been invested in this sector for more than a minute knows it is really hard to tell what is good for this sector. It's been mostly bad. Then there was earnings week. None of the reports were surprisingly good, or spectacularly bad. Meh. It seems we have hit the doldrums of companies treading water and hoping to survive until there is reform. It has been far too long coming. I really don't expect much more on the 17th other than a report that the hearings were completed, objections were considered, and they will move forward with the 'process' of rescheduling. How long this 'process' will be is the key. Maybe a timeline will emerge. Is this a big enough issue to get resolved just before the mid-terms and hopefully sway a few on the fence voters? Not sure. I don't think this sector is really on anyone's radar; particularly sobering was yesterday's volume. Even those MSOs and LPs that reported earnings did not even trade their normal daily volume. I take this as a sign that nobody is interested. It comes down to S3, 280e, SAFER, and uplisting. Trulieve demonstrated that uplisting without rescheduling is not the answer. I expect most institutional investors will stay away (for legal reasons) until rescheduling allows them to invest. Uplisting alone will not attract institutions. It will have to be reschedule, 280e clarification, then institutions. I also believe the average retail investor has seen enough carnage here to support the idea of waiting until there is a definitive change in the wind. Will that change be signalled on 17 Aug? I am not holding my breath. The only aspect left is the "surprise" factor. Maybe something will come out of left field. Who knows. On a personal note, weedstocks has completely changed my approach to risk. I am now a 'scared' investor in other sectors which makes me somewhat weaker. For example, with all of the negative press about SpaceX, I came close to buying when it was hovering around 100USD as this was about 40% off of its IPO price. For those who might recall Facebook, it had a similar trajectory before taking off. When I saw SPCX at 105 I was tempted to buy, but then my "weedstocks thinking" kicked in which is basically "it will go lower". Yesterday I watched companies in this sector do "okay" on low volume post earnings while SPCX jumped 15% on twice the average volume. Foodcooker makes much about meme stocks, yet here is a company that is nowhere close to a profit about to unlock 20% more shares and it goes up 15%. Sounds like a weedstock around 2021! I remain invested in this sector for two primary reasons. The first is my belief in the medical aspects of CBD. It has been a game changer for me in terms of easing arthritis pain. I have not taken a Tylenol in over five years. CBD (used to use oil, now gummies) takes the pain away and I get a much better night's sleep. Low does THC drinks now have my attention. I am not out to get 'stoned' or too high when socializing. I do enjoy having a few drinks in a social setting and like how a bit of alcohol functions as a mood enhancer. The idea of achieving this with a low calorie alternative that won't harm my liver is enticing. The lobbyists and gatekeepers in government make a lot of noise about marijuana being a 'gateway drug'. This is where I think this sector could do better. The best news I have heard in awhile is the move toward low dose THC drinks. Right now less is more in the alcohol industry. I am seeing ads for Arkay vodka as a "zero calorie zero alcohol" alternative. The ad shows a bunch of young people just coming off of their workout and gathering around for a shot of Arkay vodka. This demographic appears to be willing to pay more for less. Something weedstocks could learn from. Low dose, no calorie, non-gateway. CBD and THC should be marketed as 'safe' alternatives. Really, that is what they are (at least for me). It's been the alcohol and pharmaceutical lobbying groups (who give politicians lots of money for re-election) that control the narrative on this sector.

GeoLogic23

Here's just some links. Listen to practically anybody in the hemp beverage and/or alcohol space talk about these products. You'll understand the shift that has been happening over the last several years. [Minnesota liquor store example](https://www.digitsagency.com/digits-from-na-to-thc-retail-media/) >The U.S. cannabis market is projected to reach $123.6 billion by 2025, with direct retail sales exceeding $35 billion. Within this massive market, beverages represent the fastest-growing format >**At Top 10 Liquor, THC drinks already account for 10% of total sales** and are expected to double by 2026. >Total Wine and regional liquor chains have gone further, replacing 10-20 feet of craft beer sets with THC products. [Minnesota overnight success JUST by switching retail.](https://hightimes.com/business/move-over-booze-weed-drinks-pulled-1-1-billion-in-u-s-sales-in-2024/) >The shift was sparked by the 2018 Farm Bill, which decoupled hemp from marijuana and opened the door for hemp-derived THC beverages to flood mainstream channels. Then came **the Minnesota effect**, where lawmakers accidentally greenlit hemp THC seltzers in bars, liquor stores and restaurants. **The state racked up over $200 million in drink sales almost overnight, and other states took notice.** [Minnesota bar](https://www.thedrinksbusiness.com/2026/02/craft-brewers-turn-to-thc-drinks-for-growth-as-legal-uncertainty-looms/) “THC is not our entire business, but it has become an increasingly important component of it,” says Ryan Bandy, chief business officer at Indeed Brewing Company in Minneapolis. **“I’d say it is responsible for about 15% to 20% of our volume and delivers 25% to 35% of our revenue.** [Minnesota bar](https://www.marketwatchmag.com/the-cannabis-drinks/) Earl Giles CEO Nick Kosevich calls cannabis drinks the most exciting new beverage segment in decades and says they’re showing the “most insane growth” he’s seen across the distillery and restaurant business......At Earl Giles restaurant, alcohol comprises 75% of beverage sales and **THC drinks make up 20%,** with non-alcohol drinks holding the remaining 5%. [Ohio bar](https://www.wkyc.com/article/news/local/ohio/ohio-bars-breweries-impact-state-law-bans-sale-thc-seltzers-hemp-weed-drink-money-alcohol/95-099e4445-d966-4232-af29-c603ccff34b2) At Jukebox in Ohio City, **THC seltzers make up nearly 10% of all sales**. [Florida bar](https://www.sun-sentinel.com/2026/04/23/buzzkill-thc-drinks-are-exploding-at-south-florida-bars-breweries-and-restaurants-but-will-they-last/) Which is why using Funky Buddha’s 115,000-square-foot warehouse for **co-packing hemp-derived THC drinks is a lucrative side hustle** [Florida liquor](https://ecrm.marketgate.com/Blog/2025/09/THC-Beverage-Consumers-Are-a-Surprisingly-Diverse-Group-at-This-Florida-Restaurant-Chain) In just six months, THC beverages have shot to 3 percent of sales at the Clearwater Beach liquor store. “That may not sound huge, but **going from zero to 3 percent that quickly is a big deal**,” Sousa says. “And we’re just getting started.” [Willie Nelson Brand sales](https://www.foodbev.com/news/willie-nelson-s-thc-beverage-brand-raises-15-million-to-fuel-us-retail-expansion) Since launching less than a year ago, the brand said it has sold more than 400,000 bottles online, achieving a projected **annualized revenue run rate of roughly $80 million**. The funding will support a retail expansion in 2026, **leveraging JuneShine Brands.....established three-tier distribution network.**

GeoLogic23

>It's also an extremely capital intensive production process compared to pre-rolls ,vapes, flower or edibles. Yes exactly, it's a much higher barrier to entry. That's why I'm saying that companies that already have beverage distribution and manufacturing are at an advantage. You can't have just anybody jump in and compete with you. There is the whole [three-tier system](https://en.wikipedia.org/wiki/Three-tier_system_(alcohol_distribution)) that gatekeeps new adult beverage brands. So many people can grow THC flower and get vapes made. That's why **prices keep racing to the bottom** in every new cannabis market. We've seen this happen for many years in many markets. What you need to do is go back and look at recent numbers being reported by various alcohol retailers and bars in the US. THC beverages are [significant percentage](https://www.reddit.com/r/weedstocks/comments/1t4atd8/comment/ok3vikk/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button) of sales for those that sell them, and they are the fastest growing segment in THC products for a while now. It's funny you say Canopy is just using beverages as a distraction, because I don't feel like Canopy talks about them that much. I'm the one whose talking about them. Canopy didn't mention beverages at all in their business highlights in this press release.

GeoLogic23

I feel like we are close, but never underestimate the government's ability to drag their feet. Drinks have definitely proven they sell in regular retail, and there's a current fight over American liquor in Canada. It seems like such an obvious move to take some of that American liquor shelf space and dedicate it to home grown Canadian THC drinks.

i-love-you-sm

I’d have to imagine we’re getting closer to Canada allowing THC beverage sales in bars, liquor stores, some retail shops. TLRY controls about 45% of the market for THC beverages in Canada.

GeoLogic23

Canada beverages still to this day are only sold in dispensaries. The beverage boom in the USA is happening in places that sell THC beverages alongside alcohol. Which is why companies with alcohol distribution networks are at an advantage, should the hemp beverage market be regulated. Look up what the three tier system is for alcohol. It's not something where you can just create a product and instantly start selling it everywhere. You need lots of distributor relationships. Tilray has a huge percentage of the Canadian beverage market. They are just hoping they'll be able to sell them to regular consumers at some point instead of just dispensary consumers.

skyplt29

This is far more significant than what most may think. So many people I know who go on a diet stop drinking alcohol, but miss it. A lower THC beverage that affords on to take the edge off without putting the pounds on has huge potential. I would venture to think the alcohol industry sees the writing on the wall.

GeoLogic23

Yes they are **significantly** lower calories because alcohol adds calories but THC does not. Another reason this market is targeting the health conscious consumer, and doing well with women. Also depending on your tastes, but i find it much easier to cover up the taste of THC compared to alcohol. So they need less sugar and stuff to make better tasting drinks.

skyplt29

Geo! How dare you say anything remotely positive about an LP. This will indeed earn you some FoodCooker wrath. I can't be bothered to logout to look. Me? I am still holding onto my tulip bulbs in the hope they will be worth thousands in a few months. Also have some South Seas tea that I am furious about it not being worth more. Seriously, if this hemp beverage thing actually works out (I read your post on that, thanks for sharing the paywalled article) those companies with established distribution channels will do well. I am firmly in the lower THC content group. I am not one who drinks to get drunk...just to take off a bit of the edge and relax. I would think low THC drinks will be a great crossover for those who enjoy a casual social drink after work. If hemp beverages can actually be served in bars...it could be massive. BTW, do you happen to know if the calorie count on hemp beverages is less than alcohol?

jmu_alumni

I don’t understand how a 1 month delay could help the broader THC framework knowing that is gets banned one month later. But I also don’t think the white house is lying to the senators…. So I just don’t understand the reasoning. I do think elections may play a role, but I would have thought that would be a reason provided

Kbarbs4421

> Trump laid out the argument to Sen. Ted Budd (R-N.C.) for why the White House supports a provision in the stopgap funding bill that would delay the ban by about a month .... The White House is working on a broader framework addressing THC products for medicinal uses, and officials are concerned the ban could complicate those plans. .... White House liaison James Braid .... committed to no further delays — beyond the one included in the short-term funding measure.

GeoLogic23

Here's what I have off the top of my head. Maybe missing some. Tier 1 (heavy focus/interest) - RYM, Tilray, Canopy, Jones Soda, Boston Beer Tier 2 (smaller part of business) - Organigram, SNDL, Trulieve, Curaleaf Tier 3 (micro caps) - cbdMD, LFTD Partners Then there are also other alcohol companies with a history in cannabis beverages. Constellation, Molson, etc.. Some have suggested that if the hemp ban does happen, it's basically just a short term ban so big alcohol can swoop in and buy up the good brands. Then there are companies like Alimentation Couche-Tard (Circle K) and Target that are retailers moving into THC beverages. Circle K would be much more affected by THC beverages gaining popularity though. Also SNDL would benefit if Canadian liquor stores were allowed to sell THC beverages.

Tiaan

>An amendment to a Senate spending bill that would remove a delay to the federal ban on most hemp-derived THC products has been ruled germane by the parliamentarian, meaning it can pass with a simple majority. It could receive a vote as soon as tomorrow. per MJHerald. Not looking good for hemp

trent_upscale

If you're reading this and you're high on THC, your family hates you because you went balls deep in HRTZ put debt spreads

GeoLogic23

# From Dispensaries To The Mainstream That familiarity is beginning to extend beyond the dispensary counter. Earlier this summer, ayrloom became the [first hemp-derived THC beverage brand with an official presence at Governors Ball](https://www.bevnet.com/pr/2026/07/22/ayrloom-sees-tremendous-growth-across-the-business), where it distributed thousands of low-dose beverages throughout the festival. For Brennan, the activation demonstrated that cannabis beverages can fit naturally into mainstream social occasions. Cuccurullo believes long-term success will depend on something simpler than potency. "Ultimately, normalization isn't about encouraging more consumption," she says. "It's about helping adults make informed choices and giving them products that consistently deliver the experience they expect." # The Bottom Line The legal cannabis industry spent its first decade proving it could build stronger products. Its second decade may be defined by building products that millions more adults feel comfortable trying for the first time.

Kbarbs4421

A few more sources: [US Senators Aim to Keep Hemp THC Product Ban on Schedule, Despite White House Pressure](https://www.cannabisbusinesstimes.com/hemp/news/15831841/us-senators-aim-to-keep-hemp-thc-product-ban-on-schedule-despite-white-house-pressure) > [**@snhandler**](https://x.com/sn_handler/status/2085015138478719328) > [News: Sen. Ted Budd's amendment to strip out the hemp ban delay is now up to 8 total GOP senators on board.](https://x.com/sn_handler/status/2085015138478719328) > [Budd, Ricketts, Lankford, Grassley, Rounds, McConnell, Cornyn and Cassidy are all supporting the amendment, I'm told.](https://x.com/sn_handler/status/2085015138478719328?utm_source)

AverageNo130

Dronabinol. a medication containing tetrahydrocannabinol (THC) significantly reduced the frequency and intensity of nightmares among patients with post-traumatic stress disorder (PTSD), according to a randomized clinical trial published in Nature. MH

GeoLogic23

I ended up on Aurora's website earlier looking for financials. Was just curious so I checked out their beverage lineup, as I know ACB had a drink they released a while back. It looks like Aurora's brands are "leaving soon" while all the "new releases" are [Organigram's brands](https://www.auroramedical.com/collections/ready-to-drink-beverages). They're pretty much only selling Organigram drinks. This could just reflect ACB moving out of all recreational channels. If they expect drinks to expand to regular retail, there's not much benefit to medical-focused ACB to continue pursuing a drink format. Since drinks in dispensaries won't stand a chance against drinks if they are in regular retail. I personally think it's not far in the future Canada will make that shift. The US has proven drinks sell when they are in regular retail, and Canada replacing American liquor with Canadian-made THC drinks is an easy PR move.

Trill4091

Tilray? THC

trent_upscale

If you're reading this and you're high on THC,

Bl1nk9

I still think they could do some marketing with pre packaged bags (not my cup o tea, but somebody must be buying the ones I am seeing.) Consistency at scale. Especially if they want to know what experience to expect. I have agreed for many moons that drinks were going to be the significant bridge builder. THC drinks and shots will be its own animal. Fwiw, I have enjoyed the few 10mg drinks I have tried in the past. Keef, & ?? Expensive for the daily, but consistent. I’d enjoy one at a concert.

GeoLogic23

Yes absolutely it's going to be tough to stand out. The beverage industry is extremely competitive in general. Let alone in a hot new market. Right now lots of the existing brands sell direct to consumer (online) and very limited retail. Most do not have the ability to scale to any size without a significant partner in the CPG space. Look at a beverage company like Celsius. They were around for years before they got with Pepsi. Then they became incredibly popular. It's all about getting the product in front of the consumer in the beverage market. Regarding bars only selling a brand or two: * Target is working with at least 6 brands. * Circle K stocks a good amount of brands. * Total Wine stocks a bunch of brands. Pretty much any of the liquor stores that sell THC drinks stock a bunch of brands. But it is a subset of like 20-30 brands that seem to be the ones really scaling well so far. You can go to [Total Wine](https://www.totalwine.com/beer/thc/c/362003), to [Binnie's](https://www.binnys.com/extras/thc/), to [Spec's](https://specsonline.com/shop/infused-seltzers/#results-top), or to any of their websites and see for yourself. You'll notice pricing has become much more reasonable too. Brands that sell in regular retail save so much money on distribution, because direct to consumer beverages is crazy expensive due to shipping. So yea idk why you are focusing on bars when you can see tons of brands being sold in other retail outlets. Bars are definitely reporting THC drinks as a significant factor in them staying in business though. I went to link a comment I remembered making, but it's literally [me already demonstrating this to you](https://www.reddit.com/r/weedstocks/comments/1t4atd8/comment/ok3vikk/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button). But even if they only stock a handful, that's a crazy amount of increased distribution for the THC beverage market. Now this part: * I absolutely did not say **most THC consumers** are about the most high for the least money. * I said **people who are smoking** only care about the most high for the least money. I keep pointing out how the dispensary and beverage markets are completely different consumers. Idk why you keep ignoring that. It's literally what started this whole beverage boom. When Minnesota was the first to allow THC drinks to be sold alongside alcohol. Sales exploded instantly, like drinks had never sold anywhere else before. This isn't my opinion. You can look at all the data. Now what happens if Target and Circle K go national? What happens when Walmart sells THC drinks next to beer? What happens when you can buy THC drinks at pro sporting events? I'm not saying any of that is definitely happening. But we have barely scratched the surface of distribution for drinks. If they are regulated, there is a huge ceiling for the top brands. But even the mid-tier brands will get a big boost in their local area. The craft beer boom was very good for local breweries all over the country for a long time.

heliumbox

> No cannabis brands have ever mattered though. Tell that to the folks at /r/TheOCS I don't disagree that drinks will help bring attention/build brands... but it also comes with the very strong caveat that they actually need to be good... they need to be able to stand out from what is bound to be saturation very akin to the craft beer boom. I just don't see them being popular enough to demand dozens of currently occupied shelf distribution space. How many bars (if even ever allowed) are going to stock more than a sparse handful (literally probably 1 or 2 similar to zero alcohol beer options) of different brands. I will continue to push back on the notion that hemp drinks are going to drive significant sales or new attention to the plant. I'm certain there is a *small* market for them, how small or not that is... who knows. I just don't see the juice being worth the squeeze because as you said, most THC consumers are about getting the most high for least money. If drinks are aimed at the small subset of "weed curious" customers and not power consumers, the market shrinks drastically again.

GeoLogic23

I absolutely think we want hemp drinks, but only drinks. I could make a case for gummies too, but definitely drinks. Drinks target a completely different consumer than those who shop at dispensaries. The distribution is within a completely different system. And the manufacturing is a high barrier to entry. I think having them would be a **rising tide lifts all boats scenario**. It opens the door to more GTI/RYM type deals, which are just backdoor ways of advertising cannabis when you aren't typically allowed to. We are also already seeing lots of celebrities and athletes getting behind THC drinks. Even those already in the cannabis market. * From 2023: [Dwyane Wade Launches Cannabis Brand, 'Hall Of Flame'](https://www.essence.com/news/money-career/dwyane-wade-cannabis-hall-of-flame/) * From Today: [The THC Drink Dwyane Wade Wanted Didn’t Exist — so He Created It](https://www.foodandwine.com/dwyane-wade-cann-collaboration-half-and-half-cannabis-drink-12032436) >The NBA Hall of Famer’s new Cann collaboration includes a microdosed THC beverage and the brand’s first THC-free drink, each made with yerba mate for a gentle caffeine lift Drinks are just so much better for brand building, and brands are what win in developed markets. * Smoking isn't going to be advertised by major companies, and pre-rolls all look the same. * Gummies are eaten in a moment, and they are tiny. * Drinks take a while to consume, while prominently displaying the brand name. No cannabis brands have ever mattered though. People who are smoking only care if it's cheap with high THC, and maybe about terpenes if they know their stuff. But they don't care whose brand it is. That's been clear for many years. Recreational flower is just a commodity. Lowest price wins. However when you are going to be holding onto a drink for an extended period of time in public, brands will matter more. And the goal with drinks is really to mainstream THC use. Beverages are a familiar format. Lots of people will stick to low dose options and that's great for them. But the rising tide lifts all boats part is when new low dose THC consumers realize they really like THC. Then those people go to a dispensary. Then all of a sudden cannabis brands DO matter, because **if they were drinking Rythm drinks to get them into the dispensary, they are far more likely to choose a Rythm cannabis product.** In theory. It's much easier to advertise a brand to a novice THC consumer, than to try to convince a stoner to buy Wiz Khalifa's overpriced mids.

UsedState7381

We actually need a carve out for THC beverages, not having that will directly hurt the bottom line of Green Thumb and Trulieve, not to mention the LPs that are dabbling in the USA market via THC beverages.

AverageNo130

A coalition of alcohol retailers are cheering Senate leaders’ inclusion of provisions in a key funding bill to [delay the planned federal recriminalization of hemp THC products](https://www.marijuanamoment.net/senate-gives-hemp-thc-products-a-lifeline-by-including-provisions-to-delay-planned-federal-ban-in-new-spending-bill/)—saying it provides industry supporters with more time to convince Congress to “establish a responsible federal framework for low-dose hemp-derived THC beverages.” MM

Allout-Okarun

Farmers carries in the sun, groceries and meal prep, cleaning the house, then a large dose of THC+researching next plays+hogwarts legacy before HoD and Sunday scaries

ImCaffeinated_Chris

THC vaginal lollypops

GeoLogic23

Cannadips is a CBD/THC pouch product that's been around for years. I follow them because they have a few different connections to Altria. One of the things I have followed about them for years is the pharma company Lexaria Biosciences. Lexaria was an investment by Altria, and Cannadips used their technology in their pouches until the last few years. Lexaria worked with Altria on nicotine R&D in the US since 2019, and also worked with BAT on nicotine R&D outside of the US in 2020. They have also worked with CBD/THC beverage companies. As of at least 2025, [Altria was still a shareholder](https://lexariabioscience.com/2025/06/23/lexaria-reaches-patent-milestone-50-patents-now-granted-worldwide/) and rights holder to Lexaria's tech for use in nicotine products. >Altria Ventures Inc. the 16.67% shareholder of Lexaria Nicotine LLC, holds a non-exclusive license to the use of DehydraTECH with nicotine products. In recent years, Lexaria has been more focused on trying to use their tech for the GLP-1 market. But they gave a [business update on 7/6/2026](https://www.thenewswire.com/press-releases/1B2aFdREV-lexaria-updates-business-development.html) with this paragraph: >In addition, Lexaria is pleased to report that interest in DehydraTECH technology is expanding once again outside of the GLP-1 industry. **Lexaria has recently received renewed incoming corporate interest in the DehydraTECH-CBD and DehydraTECH-nicotine sectors** where the Company has conducted extensive previous R&D validating the efficacy of the DehydraTECH technology. Now if it was just renewed interest in CBD, it might be their beverage/food connections. But it's interesting that they have renewed interest in both CBD/Nicotine at the same time. Given the type of products that they use their tech in, the obvious crossover between CBD/nicotine would be in pouch products.

AverageNo130

Rep. James Comer (R-KY), who chairs the House Oversight and Government Reform Committee, is circulating legislation that would delay a planned federal ban on hemp THC products and institute some regulations—including packaging requirements, testing rules and age limits. MM

ForestThroughDaTrees

A few companies have tried cannabis pouches but they end up getting absorbed through swelling your spit and then into your liver. So they’re no different than a standard edible. If Capsoil has figured out how to get THC to go directly into your blood it would be interesting.

GeoLogic23

Here are a few of the things I was thinking about why pouches may be a choice for some people/companies. This is stuff I've been thinking of for a while, because I used to follow another pouch company called Cannadips. Cannadips has long been an investment by Poseidon (Tilray connected), have connections to big tobacco (Altria), and use emulsion tech connected to pharmaceutical CBD (Lexaria Biosciences). Absorption. * Pouches absorb directly into the bloodstream instead of going through your digestive system. Should mean quicker more consistent dosing, and may help people who aren't affected by edibles. Regulation. * A different form factor could come with different regulatory approvals. We have already seen this administration be friendly to ZYN. I could see big tobacco getting a pouch with CBD approved as a less harmful smoking alternative. There are studies about CBD being used for cravings like nicotine. If they were trying to get an ingestible product approved, it wouldn't be regulated by the TTB, it would be the FDA. Distribution. * Tilray is aligning themselves with alcohol distribution for THC drinks, where the convenience store market is a big focus area. Gummies are better for retail that distributes supplements. But pouches would make a lot of sense to be sold at convenience stores alongside beverages, since convenience stores already sell nicotine pouches in an age-gated way. Convenience. * Pouches are very small and easy to carry. A construction worker for example, would rather carry pouches than have a bunch of melted gummies at the end of the day. Also very easy to mix a THC pouch with a caffeine/nicotine pouch to get the hippy speedball effect. You don't have to keep a pouch cold like a drink. Doubt THC pouches are going to replace white Monster Energy for construction workers anytime soon though lol Safety. * I know there is some concern about nano-particles accumulating in vital organs. It's one reason the EU set a very low safe threshold for CBD in food right now. They just don't' have enough long term safety data yet. A pouch product being absorbed in your gums might not have that same issue, but I'm not sure if that's the case or not. Think of it this way. People could get their nicotine fix with **nicotine gum**. But they don't. They could use **nicotine lozenges**. But they don't. Yet **nicotine pouches** became the next big thing for some reason. And this is me purposefully playing the pro-pouch side of the argument. I don't use any sort of pouch product myself, so I honestly don't understand why it's so appealing. But I can't argue with the numbers lately in the tobacco industry.

GeoLogic23

I have said it a bunch, but my thoughts are that their plan literally is to moth ball those underperforming alcohol assets. I think they are waiting to switch them out for THC beverages. They just can't moth ball them until they are actually allowed to replace them with their THC brands, or else someone else will take that distribution and retail shelf space. Remember that there aren't even THC beers on the market right now, and a lot of Tilray's shelf space and consumer base is beer. So until hemp is resolved, the losses they are incurring on those alcohol brands are essentially just renting them shelf space, until they can properly utilize it with higher margin THC drinks.

AverageNo130

States that impose high tax rates on regulated marijuana products are driving adult consumers to the illicit market, according to a new federally funded study published in the journal Health Economics. MM >Banning Hemp THC Products Drives Consumers Toward Licensed Marijuana Businesses, Poll Shows. The survey was conducted by cannabis telehealth platform NuggMD and provided exclusively to Marijuana Moment.

manualCAD

There is not a person out there who has"issues with edibles" that will utilize this pouch form..... There is literally a THC product that is tasteless powder you can add to anything. These pouches don't serve any actual market...they are just trying to tag along on the pouches trend/fad.

GeoLogic23

Tilray recently introduced a new THC pouch product. Kind of odd, considering pouches haven't been that big in cannabis. Of course they are huge in the tobacco world, but Tilray is mostly alcohol connected. Tilray's primary connection to tobacco is their years long partnership with BAT-funded Charlotte's Web. Tilray's new THC pouches use an emulsion technology that is made by [Capsoil Technologies](https://capsoil.com/liposoll/). Capsoil is funded by Matthew Bronfman, whose family built the liquor brand Seagrams. Capsoil at one point had their own California edibles brand called It's All About Choices. They did lots of powdered edible mixes, [including THC infused potatoes!](https://itsallaboutchoices.us/mixes/garlic-mashed-potatoes/) Matthew Bronfman and his son Zeke also have a current alcohol venture called Next Century Spirits. At this company they have partnered with golf legend Greg Norman to launch Caddy Cocktails. Years ago Greg Norman was [partnered with both Tilray and GGB (Aphria)](https://www.newcannabisventures.com/green-growth-brands-taps-tilray-and-authentic-brands-for-greg-norman-branded-cbd-products/). Zeke Bronfman would also start another company in 2023. This is a [powdered supplement company called The Absorption Company](https://www.absorbmore.com/). This company uses Capsoil's technology. Thus far I have only found a few companies that use Capsoil, and they are all directly connected to the Bronfmans. So if that pattern holds, Tilray should have a current connection to a Bronfman company. * Tilray has been partnered for years with Charlotte's Web, whose chairman is supplement industry veteran Angela McElwee. * In April of 2025, Angela McElwee was appointed executive chairman of Zeke Bronfman's The Absorption Company.

AverageNo130

Wisconsin’s governor is pushing congressional lawmakers to take action to [“prevent mass disruption of the hemp industry” by stopping the planned federal recriminalization of hemp THC products](https://www.marijuanamoment.net/wisconsin-hemp-business-owners-worry-about-newly-approved-federal-ban-on-thc-products/) that’s set to take effect later this year. MM

Hot_Sacks

Wth how is THC at 358 in pre market after it already popped last week from earnings

IvoryTowerResident

you missed the best one THC

manualCAD

I'm seeing TLRY's new thc pouch product announcement. Has anyone here ever used THC pouches? Thoughts? Why would I ever use a pouch form over just eating an edible (unless I was trying to wean off nicotine pouches)?

Allout-Okarun

Good weekend to start a caffeine and THC detox but how will o trade without my superpowers

AverageNo130

Sen. Tim Sheehy (R-MT) is previewing forthcoming bipartisan legislation to reverse the scheduled federal recriminalization of hemp THC products this year and replace it with a new regulatory system that includes age limits and taxes. He said the issue is “important to me personally” as a wounded veteran “who has a lot of friends who’ve gone through various stages of healing after the war” and also as someone who represents an agriculture-focused state. MM

Equivalent_Smell_325

I've been on the sideline looking at this stock for some time now Here are the bad things I noticed: \- like all LP their cad business is not doing well, net fell by 9%, margin declined by 2% to 31%, adjusted EBITA fell 82% to just 0.9 mil CAD. And free cash flow was negative at 7 mil \- dilutions that may or may not happen due to the sanity acquisition \- lost another 5.8 mill due to the hemp THC business dying in the US good things I noticed: \- probably still no 1 in the Cad market for rec cannabis? \- sanity's revenue gross margin last year went from 15% to 47%, so it's a good acquisition, OGI said they are expecting around 25 mill EURO in average quarterly revenue over 2026 \- BAT is still committed just my own 2c

Charming-Rooster7462

unfortunately this isn’t helping the state of NC. there has been a law put in place to mess up the whole THC hemp drinks. 🤬

CornMonkey-Original

ask for medication and supplement with 2x THC and you’ll be great. . . this is not financial advice, but could be a useful strategy - so I’ve heard.

DaveHervey

Nice to hear a crop was harvested. thanks for the news read this article and you might believe its a bigger market: Opinion: The Coming Divide Between Pharma THC and Retail Cannabis https://www.reddit.com/r/TLRY/comments/1us20dh/opinion_the_coming_divide_between_pharma_thc_and/ "2. Cannabis crosses the U.S. border legally for the first time April’s rescheduling order did something no cannabis policy before ever did: It placed marijuana drug products and state-licensed medical marijuana on the Schedule III import and export list. A single cannabis-derived drug had crossed under research permits before. This is a standing commercial pathway, and that is new. Every country that spent the past decade building medical cannabis for export — Israel, Colombia, Canada, the Netherlands — now has a legal door into the largest market on earth. The first permits will move FDA-approved products and Active Pharmaceutical Ingredients. State-licensed material is likely to follow as the frameworks catch up. But the wall around American cannabis was the last one standing, and it just grew a gate. Once foreign material lands cheaper than domestic material, the pressure runs in only one direction".

Beginning-Fig-9089

Caffeine and THC, im ready for Power Hour!

Severe-Selection-256

Fk had some THC gummy’s yesterday passed tf out early I thought that only happend to seniors LOL

GeoLogic23

[Beam Suntory](https://en.wikipedia.org/wiki/Suntory_Global_Spirits) (now Suntory Global) is the Japanese liquor company that bought Jim Beam. Jim Beam is often associated with GTI, because Ben Kovler's family made their money building Beam. Until a few years back Suntory had their US headquarters in Chicago. There were also rumors a couple years ago that [Suntory was going to acquire Boston Beer](https://www.reddit.com/r/weedstocks/comments/1d4piqr/comment/l6jfawi/?utm_source=share&utm_medium=web3x&utm_name=web3xcss&utm_term=1&utm_content=share_button). Boston Beer is one of the alcohol companies that really want hemp beverages to be regulated. They've been doing THC beverages in Canada for years. The Suntory/BBC talks were interesting to me because GTI was also publicly trying to merge with Boston Beer around that time. [Beam Suntory and Boston Beer already have a partnership](https://www.bostonbeer.com/news/2021/07/beam-suntory-and-the-bbc-partner-to-expand-iconic-brands) where they support each others brands, such as Truly. Beam Suntory just posted their first 2026Q2 lobbying disclosure. This marked [Suntory's first ever mention of cannabis/hemp](https://lda.senate.gov/filings/public/filing/612e8e67-77bc-4034-ad2e-5cae47326667/print/): >Issues related to taxation of hemp-derived beverages.

GeoLogic23

I think the following is a better way to summarize my opinion. I don't know whether it will be fuckery through rescheduling bifurcation, through SAFE having THC limits, through a replacement 280e tax on rec, or something else. I just don't think we emerge on the other side of this with the federal government treating medical and recreational cannabis exactly the same. I just cannot see them giving a big break to smokeable high dose recreational cannabis, without there being some sort of catch involved that gives medical cannabis a leg up.

GeoLogic23

>Your bias is that you think it is a better investment Do you think that I only invest in hemp/CBD opportunities??? I think you may only notice those comments because they stand out against all the MSO talk. I think there are great investments all over the place, which I often talk about. I just don't like the largest public MSOs because they have too much debt and no path to serious profitability. I thought I had been pretty vocal that people were sleeping on Glass House. They had been my biggest MSO investment for a while (technically not an "MSO"). After the raid I argued it was a buying opportunity, which was correct. Recently I brought up LEEF as a micro cap that should be considered due to the importance of extracted products in the upcoming CPG cannabinoid landscape. I am up about 60% on my LEEF investment from the time I brought them up. I often talk about InterCure, which is an Israeli medical cannabis company I have followed for years. Been able to trade my way to a little profit and a really good average. I have long discussed them as a company nobody talks about, with an abnormally high level of both risk and reward. I have also talked for years about Miracle Gro moving on the US THC market, by doing a roll up of smaller operators. This is exactly what Miracle Gro is now doing with Vireo. Because of cannabis I am a long time investor in Miracle Gro, and more recently in Vireo. Though I am trying to invest in Vireo via Fluent. Something I also discussed here. Idk why that deal hasn't closed yet. I could go on with more examples. Pretty much the **only** part of the hemp/cannabis market I am not heavily invested in are the largest MSOs. My only exception to that was GTI.

heliumbox

I just don't see the argument as "is recreational weed medically beneficial" that isn't the point of recreational substances. It doesn't have to be medically beneficial. So if "getting high" isn't the point of the drug then medical weed would already be shot down and we'd only have THC free medical for the actual compounds. The argument is really "is getting high for recreation" allowed. What constitutes abuse is wildly up for interpretation and varies by many many factors. S3 IMO makes very little sense for a recreational substance. Either it gets descheduled or remains illegal because for some reason weed needs to pass impossible standards other recreational substances never could. And as far as your bias/GOP bias is concerned it is just that, a bias. GOP is bias because they have big money behind it and they hate people having control over their own decisions. Your bias is that you think it is a better investment, which is fine and likely correct in our current political landscape. Personally I see hemp as a horribly low margin consumer good with low barrier to entry and an already and easily saturated market. Will reform / reinstating the loop hole come before recreational weed? almost certainly. Will it make enough money to justify investing in it? Who knows.

Lebempe

https://www.nist.gov/news-events/news/2025/07/nist-makes-first-detection-cannabis-breath-edibles "In the new study, NIST’s partners at the University of Colorado Anschutz Medical Campus observed 29 participants who each brought a cannabis-infused gummy to the lab with them. The edibles contained anywhere from 5 to 100 milligrams of THC. Researchers first took a breath sample from the participants before they ingested the product. Then they observed each participant for three hours, obtaining breath samples approximately every hour. NIST researchers measured the concentration of THC and other cannabinoids in breath at those intervals. They detected THC in most of the participants before they took the edible, even though they had been asked to abstain for eight hours before the study. That wasn’t surprising. Our bodies process cannabinoids slowly, taking weeks to get them out of our systems compared with hours for alcohol. The researchers found that 19 of the participants showed significant increases in THC in the three-hour period after ingesting the edible. Many of them exhibited a peak and then a decline in THC concentration during that time. Four of the participants did not show any change in THC, and six showed only a decrease from their first breath sample."